Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)Karoui, M ; Rullier, A ; Piessen, G ; Legoux, J L ; Barbier, E ; De Chaisemartin, C ; Lecaille, C ; Bouche, O ; Ammarguellat, H ; Brunetti, F ; Prudhomme, M ; Regimbeau, J M ; Glehen, O ; Lievre, A ; Portier, G ; Hartwig, J ; Goujon, G ; Romain, B ; Lepage, C ; Taieb, JAnnals of surgery, 2020-04, Vol.271 (4), p.637-645 [Periódico revisado por pares]United States: Copyright Wolters Kluwer Health, Inc. All rights reservedTexto completo disponível |
|
2 |
Material Type: Artigo
|
Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer A Randomized, Double-Blind, Phase III Study (HORIZON II)Paulo M. Hoff Andreas Hochhaus; Bernhard C Pestalozzi; Niall C Tebbutt; Jin Li; Tae Won Kim; Krassimir D Koynov; Galina Kurteva; Tamás Pintér; Ying Cheng; Brigitte van Eyll; Laura Pike; Anitra Fielding; Jane D Robertson; Mark P SaundersJournal of Clinical Oncology New York v. 30, n. 29, p. 3596-3603, 2012New York 2012Acesso online. A biblioteca também possui exemplares impressos. |
|
3 |
Material Type: Artigo
|
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot studyPintova, Sofya ; Dharmupari, Sirish ; Moshier, Erin ; Zubizarreta, Nicole ; Ang, Celina ; Holcombe, Randall F.Cancer chemotherapy and pharmacology, 2019-09, Vol.84 (3), p.591-598 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
4 |
Material Type: Artigo
|
Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemmaRibeiro, Maria João Marques; Alonso, Teresa; Gajate, Pablo; Molina, Javier; Barquin, Arantzazu; Perna, Cristian; Grande, EnriqueAutopsy and Case Reports; Vol. 8 Núm. 1 (2018); e2018005Universidade de São Paulo. Hospital Universitário 2018-03-13Acesso online |
|
5 |
Material Type: Artigo
|
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trialKaroui, Mehdi ; Rullier, Anne ; Luciani, Alain ; Bonnetain, Franck ; Auriault, Marie-Luce ; Sarran, Antony ; Monges, Geneviève ; Trillaud, Hervé ; Le Malicot, Karine ; Leroy, Karen ; Sobhani, Iradj ; Bardier, Armelle ; Moreau, Marie ; Brindel, Isabelle ; Seitz, Jean François ; Taieb, JulienBMC cancer, 2015-07, Vol.15 (1), p.511, Article 511 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)Wang, Feng ; He, Ming-Ming ; Xiao, Jian ; Zhang, Yan-Qiao ; Yuan, Xiang-Lin ; Fang, Wei-Jia ; Zhang, Yan ; Wang, Wei ; Hu, Xiao-Hua ; Ma, Zhi-Gang ; Yao, Yi-Chen ; Zhuang, Zhi-Xiang ; Zhou, Fu-Xiang ; Ying, Jie-Er ; Yuan, Ying ; Zou, Qing-Feng ; Guo, Zeng-Qing ; Wu, Xiang-Yuan ; Jin, Ying ; Mai, Zong-Jiong ; Wang, Zhi-Qiang ; Qiu, Hong ; Guo, Ying ; Shi, Si-Mei ; Chen, Shuang-Zhen ; Luo, Hui-Yan ; Zhang, Dong-Sheng ; Wang, Feng-Hua ; Li, Yu-Hong ; Xu, Rui-HuaClinical cancer research, 2022-10, Vol.28 (19), p.4232-4239 [Periódico revisado por pares]United States: American Association for Cancer ResearchTexto completo disponível |
|
7 |
Material Type: Artigo
|
Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer: A Brown University Oncology Research Group Phase II Study (BrUOG295)Raufi, Alexander G ; Breakstone, Rimini ; Leonard, Kara ; Charpentier, Kevin ; Beard, Rachel ; Renaud, Jennifer ; Cavanaugh, Lindsey ; Sturtevant, Ashlee ; MacKinnon, Kelsey ; Almhanna, Khaldoun ; Olszewski, Adam ; Safran, Howard PAmerican journal of clinical oncology, 2020-12, Vol.43 (12), p.857-860 [Periódico revisado por pares]United StatesTexto completo disponível |
|
8 |
Material Type: Artigo
|
FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumorsLacombe, Caroline ; Perrier, Marine ; Hentic, Olivia ; Brixi, Hedia ; De Rycke, Ophélie ; Cros, Jérôme ; Rebours, Vinciane ; Cadiot, Guillaume ; Ruszniewski, Philippe ; Mestier, LouisJournal of neuroendocrinology, 2023-01, Vol.35 (1), p.e13227-n/a [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
9 |
Material Type: Artigo
|
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314)Modest, Dominik Paul ; Karthaus, Meinolf ; Kasper, Stefan ; Moosmann, Nicolas ; Keitel, Verena ; Kiani, Alexander ; Uhlig, Jens ; Jacobasch, Lutz ; Fischer v. Weikersthal, Ludwig ; Fuchs, Martin ; Kaiser, Florian ; Lerchenmüller, Christian ; Sent, Dagmar ; Junghanß, Christian ; Held, Swantje ; Lorenzen, Sylvie ; Kaczirek, Klaus ; Jung, Andreas ; Stintzing, Sebastian ; Heinemann, VolkerEuropean journal of cancer (1990), 2022-09, Vol.173, p.297-306 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)Tintelnot, Joseph ; Goekkurt, Eray ; Binder, Mascha ; Thuss-Patience, Peter ; Lorenzen, Sylvie ; Knorrenschild, Jorge Riera ; Kretzschmar, Albrecht ; Ettrich, Thomas ; Lindig, Udo ; Jacobasch, Lutz ; Pink, Daniel ; Al-Batran, Salah-Eddin ; Hinke, Axel ; Hegewisch-Becker, Susanna ; Nilsson, Sven ; Bokemeyer, Carsten ; Stein, AlexanderBMC cancer, 2020-06, Vol.20 (1), p.503-10, Article 503 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |